Psychedelic Prescriber Training
Online prescriber education for regulated clinicians covering screening, clinical considerations, prescribing fundamentals, medication interactions, contraindications, risk management, treatment-team coordination, and Canadian access pathways.
Provider
Details
Enrollment
Course Overview
Psychedelic Prescriber Training is a clinically focused masterclass for physicians and nurse practitioners working in regulated medical settings. It is designed to build practical understanding of prescribing pathways, risk mitigation, and the Canadian regulatory context for psychedelic-assisted psychotherapy. The curriculum covers neurobiology and neuropharmacology, dosing, evidence appraisal, drug interactions, contraindications, adverse events, patient populations, and special medical considerations. It also addresses TheraPsil roles, assessment and referral, SAP pathways, Section 56 considerations, documentation, and collaboration with care teams. The format is fully online and combines pre-readings, training videos, a live seminar, a live Q&A, and a short quiz. The listed time commitment is 8 hours total, and there are separate psilocybin and MDMA versions with different clinical examples and case framing.
Who is this for?
Primarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Prerequisites
Intended for regulated clinicians; no additional prerequisites stated.
About the Provider
TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.
View TheraPsil profileCourse Details
- Price$750
- FormatHybrid
- Lifecycle statusNo New Dates
- SkillsHarm ReductionPsychotherapyPsilocybin TherapyMDMA-Assisted TherapyEthicspsychedelic prescribingscreening and assessmentcontraindication reviewmedication managementrisk mitigationdosing protocolsevidence interpretationCanadian regulatory pathwaysSAP workflow awareness
- Categories
Related Courses
View all coursesAre Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?
By Double Blind
An article examining whether ketamine clinics could serve as a model for future legal psychedelic therapy. It discusses current ketamine clinic practices, emerging regulation questions, and how clinics are preparing for MDMA and psilocybin services.
Certificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
By California Institute of Integral Studies (CIIS)
A 12-month certificate in psychedelic-assisted therapies and research housed in the CIIS Center for Psychedelic Therapies and Research. The program offers hybrid or online training covering clinical competencies, research, ethics, and culturally informed approaches.
Next cohort: Jul 13, 2026
Certificate in Psychedelic-Assisted Therapies and Research
By Fluence
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.